Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Going vertical, I like it
My bad, the link is a bit misleading, they are not on the board, but affiliated somehow, they list it as a "relationship" lol
http://www.bloomberg.com/research/stocks/private/relationship.asp?personId=672954&privcapId=624404&previousCapId=121269&previousTitle=APTOSE%20BIOSCIENCES%20INC
Seems like a logical step if the software is as good as they seem to imply.
Didn't see this come up till now. Interesting that the board has quite a few CERE members on it and when you look at what they do maybe there more synergies with Persephone than meet the eye.
http://www.bloomberg.com/research/stocks/private/relationship.asp?personId=672954&privcapId=624404&previousCapId=121269&previousTitle=APTOSE%20BIOSCIENCES%20INC
http://aptose.com/
Looks like these guys have been as of 9/30. They are late with the 12/31 and am curious what they did the last quarter of 14. In Q3 they signed on with 1,614,032 shares from 0. Must have had a good reason to take the plunge.
MARXE AUSTIN W & GREENHOUSE DAVID M
Read more: http://www.nasdaq.com/symbol/cere/institutional-holdings/new#ixzz3SxPw15oj
I had no clue until Stock brought it up, learned something new. Going to get interesting rolling into the meeting on the 12th.
I see what you mean, looks like the dumped 1.2M shares or so from their previous filing.
Good riddens.
http://www.sec.gov/Archives/edgar/data/767884/000089375014000009/sch13ga.htm
Schedule 13G filed for CERE. Wonder what this will bring to the table?
http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=GIMB:BB
http://secfilings.nasdaq.com/filingFrameset.asp?FileName=0000893750-15-000025%2Etxt&FilePath=%5C2015%5C02%5C24%5C&CoName=CERES%2C+INC%2E&FormType=SC+13G%2FA&RcvdDate=2%2F24%2F2015&pdf=
And a New Patent.
United States Patent 8,962,921
Christensen , et al. February 24, 2015
Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
MMTC Wrap-Up
13:53 23 February in Events by Persephone Team
Thanks to MMTC attendees who stopped by our booth. Good discussions on how Persephone can make genomics data more accessible to medical researchers and practitioners. Lots of demonstrations for a diverse audience, ranging from academic cancer genomics scientists to medical diagnostics companies. See the benefits of exploring your own data in a new way with our free trial offer.
Interesting tidbit. One of the funds buying up some shares per the last 13F is Renaissance Technologies.
Interesting bio
http://www.insidermonkey.com/hedge-fund/renaissance+technologies/5/
Making the rounds finally.
Ceres: Biofuels Digest’s 2015 5-Minute Guide
February 22, 2015 | Jim Lane
5-Minute-Guide-logoCeres develops & markets low-carbon, non-food grasses for advanced biofuels and biopower. It’s energy crops “can provide more fuel or electricity, new opportunities for growers and a cleaner environment for us all.”
Using advanced plant breeding and biotechnology, Ceres is developing dedicated energy crops as raw materials for renewable transportation fuels, electricity and bio-based products.
The company aims at increasing yields, lowering costs, facilitating processing and refining, and even helping reduce greenhouse gases.
Many of the same traits that benefit energy crops also benefit traditional row crops. So, Ceres supplies traits and technology to other well-known crop developers of corn, soy and other non-energy crops. The company utilizes genomics and model systems, compositional analysis, and marker-assisted plant breeding — as well as specialized, high-throughput systems to accelerate the company’s product development process.
Rankings
50 Hottest Companies in Bioenergy: #32, 2014/15
Biofuels Digest Awards
2012 New Feedstock (Trial) Award: Ceres, sweet sorghum
The Situation
Last year, it was “Brazil, Brazil, Brazil,” but recently the company has annoucned a breakthrough into the exciting world of sorghum hybrids — a crop very much on the rise.
Last season, the company’s Blade brand hybrids performed well in large-scale evaluations with livestock and dairy producers, out-yielding current sorghum hybrids and comparing favorably to other forage crops, such as corn silage, which is planted for its high nutritional value.
That opens more opportunities in Brazil, but also the US and China among other locales. In ties in well to Ceres ‘ Brazilian operation, of course, since the company announced last July that the company will enhance its product development programs in Brazil and expand its development activities in biotech traits for sorghum and sugarcane over the next four years. The programs will now be funded in part under the Brazilian government’s PAISS Agricola initiative, which promotes agricultural innovations in sugarcane as well as other energy crops. Under the PAISS program, Ceres is eligible for a multi-year credit facility of up to 75.4 million reais, or approximately US$34 million, at a government-subsidized, preferential interest rate. Receipt of the loan will be subject to customary diligence, documentation and closing conditions, and will require guarantees to be provided by or obtained by Ceres.
For the 2014-2015 growing season in Brazil, total plantings of the company’s sorghum products cover more than 4,000 hectares compared to approximately 1,000 hectares planted the previous season. The increase in planted area is due primarily to increased demand for high biomass sorghum for power generation. Following a dry start to the growing season, which delayed some plantings, growing conditions have been generally favorable to date across most evaluation regions, including adequate rainfall. Overall plantings were lower than the company’s original forecast of 5,000 hectares due to some weather delays at the beginning of the season, which provided less time to plant, and the company’s subsequent decision not to plant outside its recommended timeframe.
Type of technology
Plant biotechnology, gene marker-assisted breeding and other genomics
Major investors
Ceres is a public company. Its common stock trades on the Nasdaq Global Market under the ticker symbol CERE. Pre-IPO investors include Warburg Pincus, Soros Private Equity Partners, GIMV and Oppenheimer.
Past milestones
In February 2015, Ceres, Inc. announced that its seed product offerings in the U.S. will include three new forage sorghum hybrids, following positive results from commercial evaluations last season as well as new university results released last week that highlighted a number of performance advantages, including the highest milk yield per acre, which is a key metric for dairy operations. The company’s expansion into the forage market is expected to bring innovative new products to growers and producers, including hybrids with higher yields, greater disease resistance and improved nutrition.
In January 2015, the company reported that its multi-gene combinations in corn achieved an approximately 25% yield advantage over controls in many of its research-scale field evaluations involving two different hybrids. These replicated field evaluations were conducted in two different climatic regions in China through the company’s development collaboration with the Chinese Academy of Agricultural Sciences. Field evaluations represent a critical stage in the development of biotech crop traits, as they provide greater insight into how traits may perform in an agricultural setting. The company has selected its best multi-gene combinations for broader field evaluations in 2015.
In July 2014, the company announced that it has licensed its Persephone genome visualization application to Bayer CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance.
In June 2014, Ceres said that it will evaluate a number of its biotech traits in sugarcane in South America. Plantings were recently completed and preliminary performance observations will be available by the end of the year. Ceres expects to receive sugar yield results in the second half of 2015 when the first growing cycle is completed. Sugarcane provides an additional out-licensing opportunity for traits that the company is developing for its own use in sorghum and other energy crops.
In February 2014, Ceres and Syngenta announced that they have extended a joint market development agreement in Brazil. The companies will move forward with their efforts to promote the use of both sweet sorghum and high biomass sorghum at Brazilian ethanol mills. Under the renewed agreement, Syngenta and Ceres will continue to collaborate on field evaluations with mills. Syngenta will evaluate its portfolio of crop protection products alongside Ceres hybrids, while Ceres will provide both seed and research support. Both companies will coordinate outreach to ethanol mills and develop industry training programs.
In February 2014, Ceres announced the pricing of an underwritten public offering of 20,000,000 shares of common stock at a public offering price of $1.00 per share. Ceres also granted the underwriters a 45-day option to purchase up to 3,000,000 additional shares of common stock to cover over-allotments, if any. Ceres expects to receive approximately $20 million in gross proceeds, before deducting underwriting discounts and commissions and offering expenses payable by the company. Ceres intends to use the net proceeds from this offering for general corporate purposes, including working capital.
Demonstrated at commercial-scale that sweet sorghum could be used as a season-extending feedstock for Brazil’s 400+ ethanol mills. The company’s high-biomass and stress tolerance traits have demonstrated biomass yield increases of ~50% under non-irrigated conditions.
Completed IPO in February 2012.
Future milestones
Ongoing commercial sales and scale-up in pace with bioenergy industry in Brazil, Europe and the United States.
Ceres Traits to Watch
Enhanced conversion: Substantial reductions in the cellulase enzyme cocktails required to release fermentable sugars from plant biomass. This trait could be a key enabler of the large-scale use of biochemical processes and fermentation
High-biomass, low-input traits: High yields and greater yield stability on low-rent, marginal land. Feedstock is 50-70% of operating costs, and land rents can be a significant cost component. These traits could provide a major lever against cost and enable larger volumes/facilities.
Business model
Seed sales and trait licenses
Competitive edge
Genetics, intellectual property, early-mover advantage
Distribution, research, marketing or production partnerships or alliances
R&D: Texas A&M (leading sorghum genetics), Samuel Noble Foundation (Switchgrass genetics) and the Institute of Biological, Environmental and Rural Sciences Institute of Aberystwyth University in the U.K. (Miscanthus genetics).
http://www.biofuelsdigest.com/bdigest/2015/02/22/ceres-biofuels-digests-2015-5-minute-guide/
Ceres offers three new seed products including forage sorghum hybrids
February 23, 2015 | Isabel Lane
In California, Ceres has announced three new seed product offerings including three forage sorghum hybrids following positive results from commercial evaluations last season.
The company’s expansion into the forage market is expected to bring innovative new products to growers and producers, including hybrids with higher yields, greater disease resistance and improved nutrition.
Ceres’ products also performed well in numerous multi-hybrid trials. For example, the University of Florida reported that one of the company’s forage sorghum hybrids, EJ 7281, was the highest yielding commercial hybrid in both their spring and summer trials in 2014. In spring trials, EJ 7281 yields were calculated at 43,000 pounds of milk per acre, or 40% higher than the nearest entry. Results from summer plantings released last week by the university showed milk yields per acre approximately 20% higher than other commercially planted hybrids.
http://www.biofuelsdigest.com/bdigest/2015/02/23/ceres-offers-three-new-seed-products-including-forage-sorghum-hybrids/
So do I, good way to begin the weekend.
Another good stat IMO, 12/31 numbers are in and institutions buying kills selling..
New Positions 7 for 2,438,457 shares
Sold Out Positions 4 for 168,405 shares
Read more: http://www.nasdaq.com/symbol/cere/institutional-holdings?page=2#ixzz3SJgMfVAy
.89, you are better than me, but I look at Artal and they are at a buck in the last offering for over 4M shares so I am staying the course. That's my story and sticking to it.
Let's see if CERE can stay in the 30's and base for the dollar push. Interesting viewpoint in this article...
Ceres Clears the Hurdle (CERE)
Ceres Inc. (NASDAQ:CERE) was toying with the idea two days ago, acted on the idea one day ago, and stands ready to etch the idea in stone today.
http://www.smallcapnetwork.com/Ceres-Clears-the-Hurdle-CERE/s/via/1789/article/view/p/mid/1/id/530/
Here is a new player as of 12/31
FRIGATE VENTURES LP 12/31/2014 713,514 713,514 New 186
Read more: http://www.nasdaq.com/symbol/cere/institutional-holdings/new#ixzz3SFKB8VqG
Sooner or later the cork is going to pop.
I'm hoping so and holding on until it plays out long term. It could go up as fast as it fell.
A close in the 30's would be a nice thing!
Me too, but wonder if they will do the RS anyway to boost the price and then hit it with the news that we all hope to see. Either way I am following Artal, they are holding tight so far and I am in it for the longer term.
I love the mayhem comment.
Shares of Ceres Inc (NASDAQ:CERE) rose by 19.44% in the past week and 4.03% for the past 4 weeks. For the past week, the counter has outperformed the S&P 500 by 17.08% and the outperformance increases to 0.18% for the past 4 weeks.
Investors in Ceres Inc (CERE) found the counter bleeding as the shares closed down 1.5574% or 0.0038 points. The trading commenced at 0.26 and the shares soon toppled to hit a low of 0.23. During this mayhem, the market participants exchanged 369,792 shares. The last traded price of the counter was 0.2402. The shares had closed the previous session at 0.244. The 52-week high of the share price is 1.62 which exceeds the current market price by a whopping 84.94%. The 52-week low of the shares is registered at 0.181. Technically, the value of 0.23 holds significance as it is the 30-day simple moving average. The trading currency is in USD.
Ceres Inc (NASDAQ:CERE) has shown a rise of 125.3% or 163,406 shares in the short positions. The bets have increased to 293,778 shares on January 30,2015 from 130,372 shares on January 15,2015. With respect to the floated shares, the shorts are 0.7%. The counters days to cover are calculated to be 1, using the standard per day volume of 413,121 shares.
Artal hasn't blinked and a few newbies starting to show up for the 12/31 reporting period. I am sticking with Artal on this one for the long run.
http://www.nasdaq.com/symbol/cere/institutional-holdings/new
Ceres Inc Short Interest Climbs by 125.3%
Feb 13, 2015 by Mark Barry
Ceres Inc (NASDAQ:CERE) has shown a rise of 125.3% or 163,406 shares in the short positions. The bets have increased to 293,778 shares on January 30,2015 from 130,372 shares on January 15,2015. With respect to the floated shares, the shorts are 0.7%. The counters days to cover are calculated to be 1, using the standard per day volume of 413,121 shares.
CERE witnessed volatile trading session. Bulls led the way in the counter of Ceres Inc (NASDAQ:CERE) which ended 6.55% or 0.015 points higher. During the day, every dip till $0.203 was used to accumulate the stock which last traded at $0.244. The close is near the highest level of the day, i.e. $0.268 and this is a sign of strong upward momentum. The volume was seen at 1,494,383 shares. The counter had ended the previous session at $0.229. The 52-week high of the shares is $1.62 and the 52-week low is $0.181. The company has 48,261,000 outstanding shares and the market cap stands at $12 million.
Shares of Ceres Inc (NASDAQ:CERE) appreciated by 2.29% during the past week but lost 28.79% on a 4-week basis. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 0.72%. Ceres Inc (NASDAQ:CERE) has underperformed the index by 29.16% in the past 4 weeks. Investors should watch out for further signals and trade with caution.
Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Companys large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomass sorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
http://www.marketsbureau.com/ceres-inc-short-interest-climbs-by-125-3/36753/
The Persephone Team will be exhibiting at the Molecular Med TriCon in San Francisco next week, Feb. 16-18, to introduce the Persephone software to the human & medical research communities. Come by booth 630 and try out the demo we will have running and give us your feedback.
We need CERE and drought tolerant crops!
U.S. Droughts Will Be the Worst in 1,000 Years
http://www.scientificamerican.com/article/u-s-droughts-will-be-the-worst-in-1-000-years/
Yep, hopefully the pieces of the puzzle will start to connect and bring in some revenue. Also am very curious to see what happens with the ICODE patent. IP is huge in the large corporate world and they have quite a bit. It was briefly touched on in the cc if I remember right. They are the hidden gem IMO
Can't wait for the day the paint is dry finally and the train leaves the station. Hopefully lots of good news leading up to the meeting.
Nice to see the heart beating again.
Thanks and lets hope they get it right.
Guess my last post about paint drying was too much for the censors. LOL, anyone know when they might announce that Persephone went live nearly 2 weeks ago. Wouldn't it have been prudent to announce and isn't it relative and material so shouldn't it be?
So far about 100K of share has been dropped by "institutions" last FY quarter and it will be real interesting when Artal weighs in with their reporting. Are they hanging in, buying more or ???
So may questions and so little from the company.
LOL, got to love the automated articles.
Ceres Inc (NASDAQ:CERE) shares are expected to touch $4 in the short term. This short term price target has been shared by 1 analysts. However, the standard deviation of short term price estimate has been valued at 0. The target price could hit $4 on the higher end and $4 on the lower end.The information is based on average recommendation on company rating and price target for short term (6 to 12 months) .
Ceres Inc (NASDAQ:CERE) : Optimism-led buying helped Ceres Inc (NASDAQ:CERE)post gains of 11.71% or 0.024 points. The mood remained fairly bullish throughout the day and no significant downmove or selling pressure was witnessed. During the day, the shares fluctuated in $0.194-$0.2345 but finally closed higher at $0.229. The shares had closed the previous day trading session at $0.205. The 52-week high of Ceres Inc (NASDAQ:CERE) is at $1.62. The volume for the day was recorded at 630,212 shares. Currently, there are 48,261,000 outstanding shares and the company has a market cap of $11 million. The 52-week low of the shares is at $0.181.
Ceres Inc (NASDAQ:CERE) has traded 1.41% of the total shares outstanding in the last 20 days. The average daily volume for the preceding 20 days is 681,375shares. The short ratio for the counter is 0.16. The short interest has changed by -26.85% in the past 1 month. The 3-month % change in short interest is -73.65%. In the past month, the total shorts are equal to 0.003 times the outstanding shares. A negative %change in the short interest reflects that bears are losing grip while a positive %change in the short interest points to a strong bearish pull over.
Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Companys large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomass sorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
Way too quiet and even I have shut up. Something brewing?
Awesome, here it is.
Oh and by the way you can now buy a subscription to the world leading, cutting edge, easiest to use, most economical genome software on the market. Try or buy it now.
https://sites.fastspring.com/ceres/instant/persephonecloudserviceannualoption
Seriously wouldn't you think they would announce something. This is for sure not a pump and dump since at least they tell you every poop the CEO does.
Have a good weekend all......
They didn't say what year! :(
Anything I can cross is crossed!
Ceres Inc (NASDAQ:CERE) has received a Strong Buy rating from First Call Corporation, a division of Thomson Reuters. The rating information was disclosed in the equity research recommendation.
Analysts from various Brokerage Firms have rated the company and commented on its price target. Ceres Inc (NASDAQ:CERE) should head towards $4 per share according to 1 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $4 per share. The higher price estimate target is at $4 according to the Analysts.
Ceres Inc (NASDAQ:CERE) ended the trading day with a decline of 2.39% or 0.0056 points. The intraday bulls never looked convincing as the stock moved only negligibly above the opening price but dropped well below it. The opening trade was registered at $0.2345 and the price peaked for the day at $0.2345. The level of $0.215 acted as a support and the last transaction was made at $0.2284. Volume had zoomed to 360,420 shares. The previous closing price is entered as $0.234. The 52-week low of the share price is $0.182. The company has a market cap of $11 million.
Ceres Inc (NASDAQ:CERE) has recorded an average daily volume of 795,666 shares for the last 20 days. The volume traded during the previous 20 sessions as a percentage of shares outstanding is 1.65%. The latest short ratio is 0.62. A high short ratio points to heavy build up of shorts while a low ratio signifies lesser short positions. Short interest has changed by -63.19% in the past 1 month. The 3-month %change in short interest was measured at -66.54%. Increase in short interests in the 1-month and 3-month period can have bearish implications for the stock. The total monthly shares shorted relative to the total shares outstanding is 0.004.
http://www.rockhilldaily.com/first-call-rating-update-on-ceres-inc/319661/
Upcoming for CERE:
. Persephone SaAS going live and for sale
. Grant money info
. mini insider buys
. ICODE patent in the works
key question, with all of that can they make some dough? Going to fun in the next weeks, months
Hopefully it is a big market, seems to be coming soon to a stock near us.
Genomics Market worth $19.0 Billion by 2018
New analysis from MarketsandMarkets "Genomics Market by Products - [Instruments (NGS platform, Microarray, RT-PCR), Consumables (Genechips, Reagents for DNA Extraction & Purification, Sequencing)], Services (Sequencing & Microarray Services, and Software) - Global Forecast to 2018" finds that the Global Genomics Market earned revenues of $11.11 billion in 2013 and estimates this market to reach over $19.0 billion by 2018.
http://www.marketsandmarkets.com/PressReleases/genomics.asp